669: PLAZOMICIN IN VITRO ACTIVITY AGAINST GLOBAL KPC-PRODUCING KLEBSIELLA PNEUMONIAE ISOLATES.
In: Critical Care Medicine, Jg. 50 (2022-01-02), S. 328-328
Online
academicJournal
Zugriff:
We evaluated the activity of PLZ and older aminoglycosides against KPC-producing I K. pneumoniae i (KPN) isolates, which often display resistance to older aminoglycosides (AMG). PLZ seems to be a suitable treatment option for infections caused by MDR KPN isolates given that PLZ was the most active among the AMGs studied. B Introduction: b Plazomicin (PLZ) is a next-generation aminoglycoside approved for the treatment of complicated urinary tract infections. [Extracted from the article]
Titel: |
669: PLAZOMICIN IN VITRO ACTIVITY AGAINST GLOBAL KPC-PRODUCING KLEBSIELLA PNEUMONIAE ISOLATES.
|
---|---|
Autor/in / Beteiligte Person: | Castanheira, Mariana ; Deshpande, Lalitagauri ; Yee, Cheung ; Das, Sandhya ; Gogtay, Jaideep ; Mendes, Rodrigo ; Sader, Helio |
Link: | |
Zeitschrift: | Critical Care Medicine, Jg. 50 (2022-01-02), S. 328-328 |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 0090-3493 (print) |
DOI: | 10.1097/01.ccm.0000809000.79396.98 |
Schlagwort: |
|
Sonstiges: |
|